| Trial ID: | L6065 |
| Source ID: | NCT05249881
|
| Associated Drug: |
Semaglutide Pen Injector
|
| Title: |
"Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2|Weight Change, Body
|
| Interventions: |
DRUG: Semaglutide Pen Injector
|
| Outcome Measures: |
Primary: Change in glycemic Index in Diabetes mellitus type-2 Patients, Once weekly Semaglutide may result to remarkably change HbA1c level with in 3 months of use, 3 months | Secondary: Weight Changes in Obese People, use of semaglutide may help obese people in controlling their weight gain., 3 months
|
| Sponsor/Collaborators: |
Sponsor: Aga Khan University | Collaborators: Rehman Medical Institute - RMI
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
EARLY_PHASE1
|
| Enrollment: |
300
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2022-03-10
|
| Completion Date: |
2022-12
|
| Results First Posted: |
|
| Last Update Posted: |
2022-08-05
|
| Locations: |
Rehman Medical Institute, Peshawar, KPK, 25100, Pakistan|Aga Khan University, Karachi, Sindh, 74800, Pakistan
|
| URL: |
https://clinicaltrials.gov/show/NCT05249881
|
